These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 28741059

  • 1. Postoperative follow-up programs improve survival in curatively resected gastric and junctional cancer patients: a propensity score matched analysis.
    Sisic L, Strowitzki MJ, Blank S, Nienhueser H, Dorr S, Haag GM, Jäger D, Ott K, Büchler MW, Ulrich A, Schmidt T.
    Gastric Cancer; 2018 May; 21(3):552-568. PubMed ID: 28741059
    [Abstract] [Full Text] [Related]

  • 2. Surveillance and outcomes after curative resection for gastroesophageal adenocarcinoma.
    Jiang DM, Suzuki C, Espin-Garcia O, Lim CH, Ma LX, Sun P, Sim HW, Natori A, Chan BA, Moignard S, Chen EX, Liu G, Swallow CJ, Darling GE, Wong R, Jang RW, Elimova E.
    Cancer Med; 2020 May; 9(9):3023-3032. PubMed ID: 32130793
    [Abstract] [Full Text] [Related]

  • 3. Comparison of postoperative survival between early-onset and late-onset adenocarcinoma of esophagogastric junction: a population-based study.
    Chen L, Jin T, Fang Y, Wu G, Yuan Y.
    J Gastroenterol Hepatol; 2024 Jun; 39(6):1073-1081. PubMed ID: 38353050
    [Abstract] [Full Text] [Related]

  • 4. Extranodal metastasis is a powerful prognostic factor in patients with adenocarcinoma of the esophagogastric junction.
    Zhang HD, Tang P, Duan XF, Chen CG, Ma Z, Gao YY, Zhang H, Yu ZT.
    J Surg Oncol; 2013 Dec; 108(8):542-9. PubMed ID: 24018956
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Tumor stage after neoadjuvant chemotherapy determines survival after surgery for adenocarcinoma of the esophagus and esophagogastric junction.
    Davies AR, Gossage JA, Zylstra J, Mattsson F, Lagergren J, Maisey N, Smyth EC, Cunningham D, Allum WH, Mason RC.
    J Clin Oncol; 2014 Sep 20; 32(27):2983-90. PubMed ID: 25071104
    [Abstract] [Full Text] [Related]

  • 9. Palliative resection for advanced gastric and junctional adenocarcinoma: which patients will benefit from surgery?
    Mariette C, Bruyère E, Messager M, Pichot-Delahaye V, Paye F, Dumont F, Brachet D, Piessen G, FREGAT Working Group.
    Ann Surg Oncol; 2013 Apr 20; 20(4):1240-9. PubMed ID: 23064779
    [Abstract] [Full Text] [Related]

  • 10. Patterns of surveillance following curative intent therapy for gastroesophageal cancer.
    Peixoto RD, Lim HJ, Kim H, Abdullah A, Cheung WY.
    J Gastrointest Cancer; 2014 Sep 20; 45(3):325-33. PubMed ID: 24756830
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. C-reactive protein/albumin ratio is a poor prognostic factor of esophagogastric junction and upper gastric cancer.
    Kudou K, Saeki H, Nakashima Y, Kamori T, Kawazoe T, Haruta Y, Fujimoto Y, Matsuoka H, Sasaki S, Jogo T, Hirose K, Hu Q, Tsuda Y, Kimura K, Ando K, Oki E, Ikeda T, Maehara Y.
    J Gastroenterol Hepatol; 2019 Feb 20; 34(2):355-363. PubMed ID: 30119141
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Postoperative complications do not impact on recurrence and survival after curative resection of gastric cancer.
    Climent M, Hidalgo N, Vidal Ó, Puig S, Iglesias M, Cuatrecasas M, Ramón JM, García-Albéniz X, Grande L, Pera M.
    Eur J Surg Oncol; 2016 Jan 20; 42(1):132-9. PubMed ID: 26385054
    [Abstract] [Full Text] [Related]

  • 15. Recurrence following curative intended surgery for an adenocarcinoma in the gastroesophageal junction: a retrospective study.
    Belmouhand M, Svendsen LB, Kofoed SC, Normann G, Baeksgaard L, Achiam MP.
    Dis Esophagus; 2018 Apr 01; 31(4):. PubMed ID: 29228216
    [Abstract] [Full Text] [Related]

  • 16. Cancer Recurrence After Esophagectomy: Impact of Postoperative Infection in Propensity-Matched Cohorts.
    Tam V, Luketich JD, Winger DG, Sarkaria IS, Levy RM, Christie NA, Awais O, Shende MR, Nason KS.
    Ann Thorac Surg; 2016 Nov 01; 102(5):1638-1646. PubMed ID: 27353482
    [Abstract] [Full Text] [Related]

  • 17. What to do after R1-resection of adenocarcinomas of the esophagogastric junction?
    Gertler R, Richter J, Stecher L, Nitsche U, Feith M.
    J Surg Oncol; 2016 Sep 01; 114(4):428-33. PubMed ID: 27333949
    [Abstract] [Full Text] [Related]

  • 18. Long-Term Survival in Patients with Gastroesophageal Junction Cancer Treated with Preoperative Therapy: Do Thoracic and Abdominal Approaches Differ?
    Kneuertz PJ, Hofstetter WL, Chiang YJ, Das P, Blum M, Elimova E, Mansfield P, Ajani J, Badgwell B.
    Ann Surg Oncol; 2016 Feb 01; 23(2):626-32. PubMed ID: 26564243
    [Abstract] [Full Text] [Related]

  • 19. Follow-up after surgery for gastric cancer: how to do it.
    Zanotti D, Baiocchi GL, Coniglio A, Mohammadi B, Ministrini S, Mughal M, Tiberio GAM, Dawas K.
    Updates Surg; 2018 Jun 01; 70(2):293-299. PubMed ID: 29582358
    [Abstract] [Full Text] [Related]

  • 20. Adenocarcinomas of the esophagogastric junction are more likely to respond to preoperative chemotherapy than distal gastric cancer.
    Reim D, Gertler R, Novotny A, Becker K, zum Büschenfelde CM, Ebert M, Dobritz M, Langer R, Hoefler H, Friess H, Schumacher C.
    Ann Surg Oncol; 2012 Jul 01; 19(7):2108-18. PubMed ID: 22130620
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.